Vanguard Group’s Harte-Hanks HHS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $878K | Sell |
291,573
-6,554
| -2% | -$21.4K | ﹤0.01% | 3814 |
|
|
2025
Q3 | $1.11M | Buy |
298,127
+785
| +0.3% | +$2.83K | ﹤0.01% | 3761 |
|
|
2025
Q2 | $1.18M | Hold |
297,342
| – | – | ﹤0.01% | 3699 |
|
|
2025
Q1 | $1.43M | Hold |
297,342
| – | – | ﹤0.01% | 3597 |
|
|
2024
Q4 | $1.53M | Hold |
297,342
| – | – | ﹤0.01% | 3640 |
|
|
2024
Q3 | $2.21M | Hold |
297,342
| – | – | ﹤0.01% | 3527 |
|
|
2024
Q2 | $2.41M | Hold |
297,342
| – | – | ﹤0.01% | 3497 |
|
|
2024
Q1 | $2.22M | Sell |
297,342
-6,868
| -2% | -$52.3K | ﹤0.01% | 3558 |
|
|
2023
Q4 | $2.07M | Hold |
304,210
| – | – | ﹤0.01% | 3590 |
|
|
2023
Q3 | $1.98M | Buy |
304,210
+17,459
| +6% | +$102K | ﹤0.01% | 3581 |
|
|
2023
Q2 | $1.57M | Buy |
286,751
+22,402
| +8% | +$152K | ﹤0.01% | 3741 |
|
|
2023
Q1 | $2.49M | Buy |
264,349
+39,941
| +18% | +$441K | ﹤0.01% | 3596 |
|
|
2022
Q4 | $2.62M | Buy |
224,408
+51,610
| +30% | +$571K | ﹤0.01% | 3565 |
|
|
2022
Q3 | $1.93M | Buy |
172,798
+68,280
| +65% | +$911K | ﹤0.01% | 3758 |
|
|
2022
Q2 | $1.33M | Buy |
104,518
+1,918
| +2% | +$16.8K | ﹤0.01% | 3990 |
|
|
2022
Q1 | $777K | Hold |
102,600
| – | – | ﹤0.01% | 4286 |
|
|
2021
Q4 | $780K | Buy |
+102,600
| New | +$815K | ﹤0.01% | 4333 |
|
|
2020
Q3 | – | Sell |
-144,265
| Closed | -$439K | – | 4114 |
|
|
2020
Q2 | $439K | Sell |
144,265
-12
| -0% | -$28 | ﹤0.01% | 3797 |
|
|
2020
Q1 | $227K | Sell |
144,277
-388
| -0.3% | -$1.15K | ﹤0.01% | 3842 |
|
|
2019
Q4 | $518K | Sell |
144,665
-1,597
| -1% | -$4.75K | ﹤0.01% | 3789 |
|
|
2019
Q3 | $446K | Hold |
146,262
| – | – | ﹤0.01% | 3838 |
|
|
2019
Q2 | $322K | Buy |
146,262
+92,087
| +170% | +$292K | ﹤0.01% | 3893 |
|
|
2019
Q1 | $194K | Buy |
54,175
+300
| +0.6% | +$1.04K | ﹤0.01% | 3931 |
|
|
2018
Q4 | $131K | Sell |
53,875
-69,700
| -56% | -$332K | ﹤0.01% | 3957 |
|
|
2018
Q3 | $881K | Buy |
123,575
+1,143
| +0.9% | +$10.1K | ﹤0.01% | 3748 |
|
|
2018
Q2 | $1.36M | Buy |
122,432
+2,021
| +2% | +$20.7K | ﹤0.01% | 3607 |
|
|
2018
Q1 | $1.11M | Sell |
120,411
-628
| -0.5% | -$5.75K | ﹤0.01% | 3626 |
|
|
2017
Q4 | $1.15M | Buy |
121,039
+47,761
| +65% | +$481K | ﹤0.01% | 3578 |
|
|
2017
Q3 | $784K | Buy |
73,278
+708
| +1% | +$6.52K | ﹤0.01% | 3651 |
|
|
2017
Q2 | $747K | Sell |
72,570
-13,830
| -16% | -$174K | ﹤0.01% | 3643 |
|
|
2017
Q1 | $1.21M | Buy |
86,400
+3,661
| +4% | +$55.7K | ﹤0.01% | 3531 |
|
|
2016
Q4 | $1.25M | Sell |
82,739
-124,180
| -60% | -$1.88M | ﹤0.01% | 3501 |
|
|
2016
Q3 | $3.35M | Buy |
206,919
+15,800
| +8% | +$260K | ﹤0.01% | 3180 |
|
|
2016
Q2 | $3.04M | Sell |
191,119
-14,873
| -7% | -$263K | ﹤0.01% | 3212 |
|
|
2016
Q1 | $5.21M | Sell |
205,992
-2,729
| -1% | -$83.8K | ﹤0.01% | 2936 |
|
|
2015
Q4 | $6.76M | Sell |
208,721
-48,098
| -19% | -$1.8M | ﹤0.01% | 2840 |
|
|
2015
Q3 | $9.07M | Sell |
256,819
-100,238
| -28% | -$4.52M | ﹤0.01% | 2656 |
|
|
2015
Q2 | $21.3M | Buy |
357,057
+8,494
| +2% | +$571K | ﹤0.01% | 2327 |
|
|
2015
Q1 | $27.2M | Buy |
348,563
+37,866
| +12% | +$2.93M | ﹤0.01% | 2199 |
|
|
2014
Q4 | $24M | Sell |
310,697
-25,234
| -8% | -$1.65M | ﹤0.01% | 2168 |
|
|
2014
Q3 | $21.4M | Buy |
335,931
+2,684
| +0.8% | +$182K | ﹤0.01% | 2176 |
|
|
2014
Q2 | $24M | Buy |
333,247
+11,267
| +3% | +$870K | ﹤0.01% | 2148 |
|
|
2014
Q1 | $28.5M | Buy |
321,980
+2,192
| +0.7% | +$171K | ﹤0.01% | 2065 |
|
|
2013
Q4 | $25M | Buy |
319,788
+9,604
| +3% | +$783K | ﹤0.01% | 2088 |
|
|
2013
Q3 | $27.4M | Buy |
310,184
+16,194
| +6% | +$1.48M | ﹤0.01% | 2002 |
|
|
2013
Q2 | $25.3M | Buy |
+293,990
| New | +$24.3M | ﹤0.01% | 1989 |
|
Other funds holding HHS
WCM
KF
RA
BCM
Vanguard Group's HHS Position: Q4 2025 in Review
Vanguard Group reduced its Harte-Hanks (HHS) stake by 2.2% in Q4 2025, selling an estimated $21.4K and leaving 291,573 shares worth $878K. The position accounts for ﹤0.01% of the portfolio, ranked #3814.
Vanguard Group first reported a position in HHS in Q2 2013 and has held it in 46 quarters since. The position peaked at $28.5M in Q1 2014. 23 funds tracked by Wall St. Rank hold HHS as of Q4 2025.
- Vanguard Group held 291,573 shares of Harte-Hanks worth $878K as of Q4 2025.
- Vanguard Group sold 6,554 Harte-Hanks shares in Q4 2025, an estimated $21.4K.
- Harte-Hanks made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3814 holding.
- Vanguard Group first reported a position in Harte-Hanks in Q2 2013 and has held it in 46 quarters since.
- Vanguard Group's Harte-Hanks position peaked at $28.5M in Q1 2014.
- 23 funds tracked by Wall St. Rank held Harte-Hanks as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.